The provincial administration for market regulation in China’s Jiangsu province yesterday held a hearing for a price-fixing investigation in the active pharmaceutical ingredient sector, it is understood. The local antitrust authority recently announced it would hold a hearing on Jan. 12 for its proposed penalty to be levied on Wuzhou Huangpu Chemical